# Is PRRT (lutetium Lu 177) therapy available in Turkey?

Source: https://oncologyistanbul.com/answers/is-prrt-lutetium-177-therapy-available-in-turkey
Last updated: 2026-07-21

Peptide receptor radionuclide therapy, or PRRT, uses lutetium Lu 177 dotatate — a nuclear-medicine treatment the National Cancer Institute describes for somatostatin-receptor-positive neuroendocrine tumors. It requires a Gallium-68 DOTATATE PET scan first to confirm your tumor takes up the tracer, and it is delivered only at centers with the right nuclear-medicine licensing and facilities. Whether it fits your case depends on your tumor type, grade and receptor status, so a free case review can flag what your reports already establish. You can verify a center's authorization yourself before you commit to anything.

## Verify at
- [NCI — Lutetium Lu 177 Dotatate](https://www.cancer.gov/about-cancer/treatment/drugs/lutetium-lu-177-dotatate) — National Cancer Institute (NCI) (checked 2026-07-21)

Related: [Neuroendocrine tumor treatment in Turkey](https://oncologyistanbul.com/neuroendocrine-cancer-treatment-turkey)